author_facet Sung, Anthony D.
Chao, Nelson J.
Sung, Anthony D.
Chao, Nelson J.
author Sung, Anthony D.
Chao, Nelson J.
spellingShingle Sung, Anthony D.
Chao, Nelson J.
Stem Cells Translational Medicine
Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
Cell Biology
Developmental Biology
General Medicine
author_sort sung, anthony d.
spelling Sung, Anthony D. Chao, Nelson J. 2157-6564 2157-6580 Oxford University Press (OUP) Cell Biology Developmental Biology General Medicine http://dx.doi.org/10.5966/sctm.2012-0115 <jats:title>Abstract</jats:title><jats:p>Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (AHSCT) associated with significant morbidity and mortality. This review focuses on the pathophysiology, clinical features, prevention, and treatment of acute GVHD. Specifically, we explain how new discoveries in immunology have expanded our understanding of GVHD, in which tissue damage from chemotherapy or radiation results in cytokine release, which activates T cells, resulting in proliferation and differentiation, trafficking to target organs, and tissue destruction and inflammation. Insights into the mechanisms of this disease relate directly to the development of preventive strategies and therapies, such as immunosuppression, T-cell depletion, calcineurin inhibitors, CCR5 antagonists, gut decontamination, extracorporeal photopheresis, and more. We also discuss how GVHD affects the gut, liver, and skin, as well as diagnosis, grading, and scoring. We end by examining future directions of treatment, including new immunomodulators and biomarkers. Understanding the immunobiology of GVHD and developing effective preventions and treatments are critical to the continuing success of AHSCT.</jats:p> Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment Stem Cells Translational Medicine
doi_str_mv 10.5966/sctm.2012-0115
facet_avail Online
Free
finc_class_facet Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNTk2Ni9zY3RtLjIwMTItMDExNQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNTk2Ni9zY3RtLjIwMTItMDExNQ
institution DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
imprint Oxford University Press (OUP), 2013
imprint_str_mv Oxford University Press (OUP), 2013
issn 2157-6564
2157-6580
issn_str_mv 2157-6564
2157-6580
language English
mega_collection Oxford University Press (OUP) (CrossRef)
match_str sung2013concisereviewacutegraftversushostdiseaseimmunobiologypreventionandtreatment
publishDateSort 2013
publisher Oxford University Press (OUP)
recordtype ai
record_format ai
series Stem Cells Translational Medicine
source_id 49
title Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_unstemmed Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_full Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_fullStr Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_full_unstemmed Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_short Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_sort concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment
topic Cell Biology
Developmental Biology
General Medicine
url http://dx.doi.org/10.5966/sctm.2012-0115
publishDate 2013
physical 25-32
description <jats:title>Abstract</jats:title><jats:p>Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (AHSCT) associated with significant morbidity and mortality. This review focuses on the pathophysiology, clinical features, prevention, and treatment of acute GVHD. Specifically, we explain how new discoveries in immunology have expanded our understanding of GVHD, in which tissue damage from chemotherapy or radiation results in cytokine release, which activates T cells, resulting in proliferation and differentiation, trafficking to target organs, and tissue destruction and inflammation. Insights into the mechanisms of this disease relate directly to the development of preventive strategies and therapies, such as immunosuppression, T-cell depletion, calcineurin inhibitors, CCR5 antagonists, gut decontamination, extracorporeal photopheresis, and more. We also discuss how GVHD affects the gut, liver, and skin, as well as diagnosis, grading, and scoring. We end by examining future directions of treatment, including new immunomodulators and biomarkers. Understanding the immunobiology of GVHD and developing effective preventions and treatments are critical to the continuing success of AHSCT.</jats:p>
container_issue 1
container_start_page 25
container_title Stem Cells Translational Medicine
container_volume 2
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792343374876901381
geogr_code not assigned
last_indexed 2024-03-01T16:50:31.36Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Concise+Review%3A+Acute+Graft-Versus-Host+Disease%3A+Immunobiology%2C+Prevention%2C+and+Treatment&rft.date=2013-01-01&genre=article&issn=2157-6580&volume=2&issue=1&spage=25&epage=32&pages=25-32&jtitle=Stem+Cells+Translational+Medicine&atitle=Concise+Review%3A+Acute+Graft-Versus-Host+Disease%3A+Immunobiology%2C+Prevention%2C+and+Treatment&aulast=Chao&aufirst=Nelson+J.&rft_id=info%3Adoi%2F10.5966%2Fsctm.2012-0115&rft.language%5B0%5D=eng
SOLR
_version_ 1792343374876901381
author Sung, Anthony D., Chao, Nelson J.
author_facet Sung, Anthony D., Chao, Nelson J., Sung, Anthony D., Chao, Nelson J.
author_sort sung, anthony d.
container_issue 1
container_start_page 25
container_title Stem Cells Translational Medicine
container_volume 2
description <jats:title>Abstract</jats:title><jats:p>Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (AHSCT) associated with significant morbidity and mortality. This review focuses on the pathophysiology, clinical features, prevention, and treatment of acute GVHD. Specifically, we explain how new discoveries in immunology have expanded our understanding of GVHD, in which tissue damage from chemotherapy or radiation results in cytokine release, which activates T cells, resulting in proliferation and differentiation, trafficking to target organs, and tissue destruction and inflammation. Insights into the mechanisms of this disease relate directly to the development of preventive strategies and therapies, such as immunosuppression, T-cell depletion, calcineurin inhibitors, CCR5 antagonists, gut decontamination, extracorporeal photopheresis, and more. We also discuss how GVHD affects the gut, liver, and skin, as well as diagnosis, grading, and scoring. We end by examining future directions of treatment, including new immunomodulators and biomarkers. Understanding the immunobiology of GVHD and developing effective preventions and treatments are critical to the continuing success of AHSCT.</jats:p>
doi_str_mv 10.5966/sctm.2012-0115
facet_avail Online, Free
finc_class_facet Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNTk2Ni9zY3RtLjIwMTItMDExNQ
imprint Oxford University Press (OUP), 2013
imprint_str_mv Oxford University Press (OUP), 2013
institution DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1
issn 2157-6564, 2157-6580
issn_str_mv 2157-6564, 2157-6580
language English
last_indexed 2024-03-01T16:50:31.36Z
match_str sung2013concisereviewacutegraftversushostdiseaseimmunobiologypreventionandtreatment
mega_collection Oxford University Press (OUP) (CrossRef)
physical 25-32
publishDate 2013
publishDateSort 2013
publisher Oxford University Press (OUP)
record_format ai
recordtype ai
series Stem Cells Translational Medicine
source_id 49
spelling Sung, Anthony D. Chao, Nelson J. 2157-6564 2157-6580 Oxford University Press (OUP) Cell Biology Developmental Biology General Medicine http://dx.doi.org/10.5966/sctm.2012-0115 <jats:title>Abstract</jats:title><jats:p>Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (AHSCT) associated with significant morbidity and mortality. This review focuses on the pathophysiology, clinical features, prevention, and treatment of acute GVHD. Specifically, we explain how new discoveries in immunology have expanded our understanding of GVHD, in which tissue damage from chemotherapy or radiation results in cytokine release, which activates T cells, resulting in proliferation and differentiation, trafficking to target organs, and tissue destruction and inflammation. Insights into the mechanisms of this disease relate directly to the development of preventive strategies and therapies, such as immunosuppression, T-cell depletion, calcineurin inhibitors, CCR5 antagonists, gut decontamination, extracorporeal photopheresis, and more. We also discuss how GVHD affects the gut, liver, and skin, as well as diagnosis, grading, and scoring. We end by examining future directions of treatment, including new immunomodulators and biomarkers. Understanding the immunobiology of GVHD and developing effective preventions and treatments are critical to the continuing success of AHSCT.</jats:p> Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment Stem Cells Translational Medicine
spellingShingle Sung, Anthony D., Chao, Nelson J., Stem Cells Translational Medicine, Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment, Cell Biology, Developmental Biology, General Medicine
title Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_full Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_fullStr Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_full_unstemmed Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_short Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
title_sort concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment
title_unstemmed Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
topic Cell Biology, Developmental Biology, General Medicine
url http://dx.doi.org/10.5966/sctm.2012-0115